Assessment of docosahexaenoic acid (DHA) biosynthesis in patients with X-linked retinitis pigmentosa (XLRP).

被引：0
|
作者：
Hoffman, DR
DeMar, JC
机构：
[1] Retina Fdn SW, Dallas, TX USA
[2] Baylor Coll Med, Childrens Nutr Res Ctr, USDA ARS, Houston, TX 77030 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2000年 / 41卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1045B418
引用
收藏
页码：S199 / S199
页数：1
相关论文
共 50 条
  • [1] Biological safety of docosahexaenoic acid (DHA) supplementation in patients with x-linked retinitis pigmentosa (XLRP)
    Hoffman, DR
    Wheaton, DH
    Lapus, MG
    Kirchoff, KE
    Birch, DG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S930 - S930
  • [2] Rod ERG function and erythrocyte docosahexaenoic acid (DHA) in x-linked retinitis pigmentosa (XLRP)
    Hoffman, DR
    Wheaton, DH
    Locke, K
    Birch, DG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3693 - 3693
  • [3] Ancillary Outcomes of the DHAX Trial: Docosahexaenoic Acid (DHA) Supplementation in X-Linked Retinitis Pigmentosa (XLRP)
    Hoffman, Dennis R.
    Wheaton, Dianna K. H.
    Spencer, Rand
    Fish, Gary
    Pearson, N. Shirlene
    Wang, Yi-Zhong
    Klein, Martin
    Takacs, Alison
    Locke, Kirsten G.
    Birch, David G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [4] DOCOSAHEXAENOIC ACID (DHA) CONTENT IN RED-BLOOD-CELLS FROM PATIENTS WITH X-LINKED RETINITIS-PIGMENTOSA (XLRP)
    HOFFMAN, DR
    BIRCH, DG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 2160 - 2160
  • [5] Safety assessment of docosahexaenoic acid (DHA) supplementation in a 4-year randomized clinical trial in X-linked retinitis pigmentosa (XLRP)
    Wheaton, DK
    Hoffman, DR
    Locke, KG
    Watkins, RB
    Birch, DG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U572 - U572
  • [6] Fatty acid profiles of blood lipids from patients with X-linked retinitis pigmentosa (XLRP) supplemented with docosahexaenoic acid (DHA) for four years
    Hoffman, DR
    Locke, KG
    Wheaton, DH
    Fish, GE
    Watkins, RB
    Birch, DG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U572 - U572
  • [7] Safety Assessment of High Dose Docosahexaenoic Acid (DHA) Supplementation in a 4-Year Randomized Clinical Trial in X-linked Retinitis Pigmentosa (XLRP)
    Wheaton, Dianna K. H.
    Birch, David G.
    Fish, Gary E.
    Spencer, Rand
    Pearson, N. Shirlene
    Takacs, Alison
    Baker, Robbie
    Hoffman, Dennis R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [8] Four-year outcomes from a randomized clinical trial of docosahexaenoic acid (DHA) supplementation in X-linked retinitis pigmentosa (XLRP)
    Hoffman, DR
    Wheaton, DH
    Locke, KG
    Fish, GE
    Birch, DG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U661 - U661
  • [9] High Dose Docosahexaenoic Acid (DHA) Supplementation in X-Linked Retinitis Pigmentosa (XLRP): A 4-Year Randomized, Controlled Clinical Trial
    Hoffman, Dennis R.
    Wheaton, Dianna K. H.
    Fish, Gary E.
    Spencer, Rand
    Pearson, N. Shirlene
    Takacs, Alison
    Klein, Martin
    Locke, Kirsten G.
    Birch, David G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [10] Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa
    Hoffman, DR
    DeMar, JC
    Heird, WC
    Birch, DG
    Anderson, RE
    JOURNAL OF LIPID RESEARCH, 2001, 42 (09) : 1395 - 1401
12345